Weitz & Luxenberg is accepting cases of patients who have required revision surgery or been advised that they need revision surgery due to tibial baseplate loosening of their Arthrex iBalance Total Knee Arthroplasty (TKA) knee replacement system.
The U.S. Food and Drug Administration (FDA) issued recalls for nearly 2,400 Arthrex iBalance knee implants in December 2015 and March 2016. To pursue action against Arthrex, Weitz & Luxenberg is accepting patients who had their knee replacement implanted prior to the FDA Arthrex iBalance recall in 2015.
Knee Replacement Device Recalled
Originally manufactured by Accelerated Innovation LLC as the Accin Total Knee System in 2008, Arthrex issued a recall for its iBalance knee replacement system in 2015 because the devices’ tibial trays were reported “to have a smooth texture to the outer surface of the metal, which differed from a previous [sic] that had a textured outer surface.” This recall was classified as Class II by the FDA in March, 2016.
The FDA determined the cause of the recall was nonconforming materials or components.
W&L Can Help Patients Harmed by Arthrex’s Recalled iBalance Total Knee Arthroplasty
Attorneys in Weitz & Luxenberg’s Drug and Medical Device Litigation unit are interested in hearing from patients who may have a failed Arthrex iBalance TKA device. From an examination of the FDA’s Manufacturer and User Facility Device Experience (MAUDE) adverse event reporting database, it appears there are many reports of these knees failing due to tibial baseplate loosening. This loosening may appear in patients as knee pain, swelling, or loss of mobility.
Patients should contact Weitz & Luxenberg if:
- You or a loved one had surgery to implant an Arthrex iBalance TKA knee replacement device prior to December 2015.
- You or a loved one required revision surgery because of tibial loosening resulting in failure of your Arthrex iBalance TKA device.
- You or a loved one were informed by your doctor that you require revision surgery due to tibial loosening of your Arthrex iBalance TKA device.
An experienced Weitz & Luxenberg attorney can help you and your family explore your legal options, including if you may be entitled to financial compensation for medical expenses, pain and suffering, and lost wages.
W&L’s attorneys, led by co-chair Ellen Relkin, have won major settlements for patients harmed by defective medical devices, including a $2.5 billion settlement for patients injured by defective DePuy ASR hip implants and a $1 billion resolution for recalled Stryker Rejuvenate and ABG II hip implants.*
W&L is also currently helping patients experiencing similar issues with the Smith & Nephew Journey Bi-cruciate Stabilized (BCS) Knee replacement system that required revision surgery due to loosening of the knee implant’s femoral component.
For a free consultation, call us at (855) 274-5624 or fill out the online form on this page to discuss your legal options.
*Past performance is no guarantee of future results. The settlements in which Weitz & Luxenberg played leadership roles included patients not represented by W&L.